These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 8000952

  • 1. Capsular retraction of the liver in malignant tumor of the biliary tract MRI findings.
    Soyer P.
    Clin Imaging; 1994; 18(4):255-7. PubMed ID: 8000952
    [Abstract] [Full Text] [Related]

  • 2. Cholangiolocellular carcinoma of the liver: CT and MR findings.
    Fukukura Y, Hamanoue M, Fujiyoshi F, Sasaki M, Haruta K, Inoue H, Aiko T, Nakajo M.
    J Comput Assist Tomogr; 2000; 24(5):809-12. PubMed ID: 11045707
    [Abstract] [Full Text] [Related]

  • 3. MRI of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (≤3 cm) with cirrhosis and chronic viral hepatitis: a comparative study.
    Sheng RF, Zeng MS, Rao SX, Ji Y, Chen LL.
    Clin Imaging; 2014; 38(3):265-72. PubMed ID: 24559750
    [Abstract] [Full Text] [Related]

  • 4. Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors.
    Ishiyama K, Hashimoto M, Izumi J, Watarai J, Shibata S, Sato T, Yamamoto Y.
    J Magn Reson Imaging; 2008 Jun; 27(6):1322-6. PubMed ID: 18504744
    [Abstract] [Full Text] [Related]

  • 5. Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US, and MR imaging.
    Campbell WL, Ferris JV, Holbert BL, Thaete FL, Baron RL.
    Radiology; 1998 Apr; 207(1):41-50. PubMed ID: 9530297
    [Abstract] [Full Text] [Related]

  • 6. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings.
    Yeh TS, Jan YY, Tseng JH, Chiu CT, Chen TC, Hwang TL, Chen MF.
    Am J Gastroenterol; 2000 Feb; 95(2):432-40. PubMed ID: 10685746
    [Abstract] [Full Text] [Related]

  • 7. CT and MRI diagnosis of hepatic epithelioid hemangioendothelioma.
    Lin J, Ji Y.
    Hepatobiliary Pancreat Dis Int; 2010 Apr; 9(2):154-8. PubMed ID: 20382586
    [Abstract] [Full Text] [Related]

  • 8. Effect of superparamagnetic iron oxide on tumor-to-liver contrast at T2*-weighted gradient-echo MRI: comparison between 3.0T and 1.5T MR systems.
    Kim T, Murakami T, Hori M, Onishi H, Tomoda K, Nakamura H.
    J Magn Reson Imaging; 2009 Mar; 29(3):595-600. PubMed ID: 19243054
    [Abstract] [Full Text] [Related]

  • 9. MR imaging of intrahepatic cholangiocarcinoma.
    Soyer P, Bluemke DA, Sibert A, Laissy JP.
    Abdom Imaging; 1995 Mar; 20(2):126-30. PubMed ID: 7787714
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic imaging of hepatic lesions in adults.
    Lamba R, Fananapazir G, Corwin MT, Khatri VP.
    Surg Oncol Clin N Am; 2014 Oct; 23(4):789-820. PubMed ID: 25246050
    [Abstract] [Full Text] [Related]

  • 11. Cholangiocarcinoma: spectrum of appearances on MR images using current techniques.
    Worawattanakul S, Semelka RC, Noone TC, Calvo BF, Kelekis NL, Woosley JT.
    Magn Reson Imaging; 1998 Nov; 16(9):993-1003. PubMed ID: 9839983
    [Abstract] [Full Text] [Related]

  • 12. Magnetic resonance imaging of cholangiocarcinoma.
    Manfredi R, Barbaro B, Masselli G, Vecchioli A, Marano P.
    Semin Liver Dis; 2004 May; 24(2):155-64. PubMed ID: 15192788
    [Abstract] [Full Text] [Related]

  • 13. Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients.
    Vilgrain V, Van Beers BE, Flejou JF, Belghiti J, Delos M, Gautier AL, Zins M, Denys A, Menu Y.
    J Comput Assist Tomogr; 1997 May; 21(1):59-65. PubMed ID: 9022771
    [Abstract] [Full Text] [Related]

  • 14. [Imaging of peripheral cholangiocarcinoma. Comparison with pathological anatomy].
    Gautier AL, Vilgrain V, Fléjou JF, Valverde A, Belghiti J, Zins M, Nahum H, Menu Y.
    Gastroenterol Clin Biol; 1996 Mar; 20(2):139-45. PubMed ID: 8761673
    [Abstract] [Full Text] [Related]

  • 15. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
    Sammon J, Fischer S, Menezes R, Hosseini-Nik H, Lewis S, Taouli B, Jhaveri K.
    Cancer Imaging; 2018 Feb 27; 18(1):8. PubMed ID: 29486800
    [Abstract] [Full Text] [Related]

  • 16. Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI.
    Kim YK, Han YM, Kim CS.
    Eur J Radiol; 2009 Apr 27; 70(1):94-100. PubMed ID: 18316169
    [Abstract] [Full Text] [Related]

  • 17. Combined hepatocellular and cholangiocellular carcinoma.
    Murakami T, Kim T, Tomoda K, Narumi Y, Sakon M, Wakasa K, Nakamura H.
    Radiat Med; 1997 Apr 27; 15(4):243-6. PubMed ID: 9311042
    [Abstract] [Full Text] [Related]

  • 18. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.
    Maetani Y, Itoh K, Watanabe C, Shibata T, Ametani F, Yamabe H, Konishi J.
    AJR Am J Roentgenol; 2001 Jun 27; 176(6):1499-507. PubMed ID: 11373220
    [Abstract] [Full Text] [Related]

  • 19. Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning.
    Masselli G, Gualdi G.
    Abdom Imaging; 2008 Jun 27; 33(4):444-51. PubMed ID: 17638040
    [Abstract] [Full Text] [Related]

  • 20. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.
    Park HJ, Kim YK, Park MJ, Lee WJ.
    Abdom Imaging; 2013 Aug 27; 38(4):793-801. PubMed ID: 22829097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.